Neuraly's Series A Round

Neuraly raised a round of funding on July 18, 2018.

Neuraly, a biotech company founded on technology created at the Johns Hopkins School of Medicine, is focused on the development of neuroprotective agents for neurologic disorders such as Alzheimer's d…

Articles about Neuraly's Series A Round: